A surprising new role has been found for a pair of compounds that have the potential to alter circadian rhythm, the complex physiological process, present in most living things, that responds to a 24-hour cycle of light and dark. At least one of these compounds could be developed as a chemical probe to uncover new therapeutic approaches to a range of disorders, including diabetes and obesity.